Genomic Characterization of Metformin Hepatic Response.

Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver. Clin Epigenetics (2017) 0.75

Use antibiotics in cell culture with caution: genome-wide identification of antibiotic-induced changes in gene expression and regulation. Sci Rep (2017) 0.75

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99

BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (2010) 53.23

Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol (2014) 27.48

HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics (2014) 23.22

Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21

Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol (2010) 16.72

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science (2005) 12.35

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2015) 12.05

HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res (2011) 11.03

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA (1999) 10.52

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature (2005) 7.14

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest (2010) 5.39

Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes (2000) 4.80

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest (2007) 4.47

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet (2010) 4.42

Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) (2012) 4.04

Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J (2009) 3.98

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature (2013) 3.72

Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol (2014) 3.66

AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem (2006) 3.53

Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J (1989) 2.89

HISAT: a fast spliced aligner with low memory requirements. Nat Methods (2015) 2.83

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther (2007) 2.80

Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell (2009) 2.69

Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet (2011) 2.68

Metformin--mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol (2014) 2.68

Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes (2007) 2.34

A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J Biol Chem (1993) 2.33

ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med (Berl) (2009) 2.08

Metformin: from mechanisms of action to therapies. Cell Metab (2014) 1.94

AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol (2010) 1.93

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia (2012) 1.83

seeQTL: a searchable database for human eQTLs. Bioinformatics (2011) 1.72

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis. Lancet Diabetes Endocrinol (2014) 1.64

Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care. Diabet Med (2007) 1.57

What is the metabolic role of phosphoenolpyruvate carboxykinase? J Biol Chem (2009) 1.57

Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J Hepatol (2013) 1.52

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia (2011) 1.48

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nat Genet (2016) 1.48

The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol (2010) 1.45

Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol (2009) 1.41

Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics (2012) 1.38

Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res (2014) 1.36

Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver. Pharmacogenomics J (2011) 1.31

Histone modifications for human epigenome analysis. J Hum Genet (2013) 1.28

The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex. Mol Cell Biol (2005) 1.28

Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5. J Endocrinol (2010) 1.28

GRASP v2.0: an update on the Genome-Wide Repository of Associations between SNPs and phenotypes. Nucleic Acids Res (2014) 1.26

AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner. J Biol Chem (2010) 1.23

The roles of ATF3 in liver dysfunction and the regulation of phosphoenolpyruvate carboxykinase gene expression. J Biol Chem (2002) 1.06

An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli. Nucleic Acids Res (2002) 1.00

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 1. Endocr Pract (2015) 0.98

Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolism. J Biol Chem (2011) 0.98

An update on the pharmacogenomics of metformin: progress, problems and potential. Pharmacogenomics (2014) 0.97

Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3). Mol Pharm (2015) 0.96

Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J Biol Chem (2014) 0.96

Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study. PLoS One (2011) 0.95

hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling. Aging (Albany NY) (2014) 0.94

Metformin limits the adipocyte tumor-promoting effect on ovarian cancer. Oncotarget (2014) 0.93

Pharmacogene regulatory elements: from discovery to applications. Genome Med (2012) 0.91

Metformin, an old drug, brings a new era to cancer therapy. Cancer J (2015) 0.90

Genome-wide discovery of drug-dependent human liver regulatory elements. PLoS Genet (2014) 0.89

Krüppel-like factors in hepatocellular carcinoma. Tumour Biol (2015) 0.86

JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity. Dev Biol (2015) 0.86

Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther (2014) 0.83

Uncovering drug-responsive regulatory elements. Pharmacogenomics (2015) 0.83

Reversal of diabetes following transplantation of an insulin-secreting human liver cell line: Melligen cells. Mol Ther Methods Clin Dev (2015) 0.80

Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action. PLoS Comput Biol (2015) 0.79

Pharmacological management of obesity in pediatric patients. Ann Pharmacother (2014) 0.79

Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes. Drug Metab Dispos (2015) 0.79

Metformin versus insulin for gestational diabetes mellitus: a meta-analysis. Br J Clin Pharmacol (2015) 0.79

The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation. BMC Genomics (2016) 0.77

Bat Accelerated Regions Identify a Bat Forelimb Specific Enhancer in the HoxD Locus. PLoS Genet (2016) 0.80